Arcus Biosciences RCUS
NYSE RCUS
$25.67 +0.66 (+2.62%)
As of: Sep 29, 2026 · 3:59 PM EDT

Arcus Biosciences (RCUS) Total Current Liabilities (2017 - 2026)

Updated

Arcus Biosciences' Total Current Liabilities was $198 million in Q2 2026, down 5.7% from $210 million a year earlier and down 5.3% from the prior quarter.

Analysis

Arcus Biosciences (RCUS) Total Current Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Total Current Liabilities at Arcus Biosciences came in at $231 million, up 2.2% from FY2024.

  • Total Current Liabilities shows a five-year compound annual growth rate of 13.7% (FY2020 to FY2025).
  • In earlier years, Total Current Liabilities was $226 million in FY2024 (+22.8%), $184 million in FY2023 (-4.7%), $193 million in FY2022 (+16.3%) and $166 million in FY2021 (+36.4%).
  • The Q2 2026 figure marks the lowest quarterly Total Current Liabilities since Q1 2025.
  • Compared with a year earlier, Total Current Liabilities was higher in six of the last eight quarters, with growth averaging 5.6%.
  • The best year-over-year quarter for Total Current Liabilities over five years was Q4 2021 (growth of 36.4%); the worst was Q3 2021 (a decline of 12.3%).
  • Per Business Quant data, RCUS's Total Current Liabilities in the three quarters before Q2 2026 was $209 million (Q1 2026), $231 million (Q4 2025) and $235 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Arcus Biosciences 3.18 Bn -157.19 Mn - 198.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 198.00 Mn
Mar 31, 2026 209.00 Mn
Dec 31, 2025 231.00 Mn
Sep 30, 2025 235.00 Mn
Jun 30, 2025 210.00 Mn
Mar 31, 2025 192.00 Mn
Dec 31, 2024 226.00 Mn
Sep 30, 2024 215.00 Mn
Jun 30, 2024 199.00 Mn
Mar 31, 2024 204.00 Mn
Dec 31, 2023 184.00 Mn
Sep 30, 2023 200.00 Mn
Jun 30, 2023 180.00 Mn
Mar 31, 2023 179.00 Mn
Dec 31, 2022 193.00 Mn
Sep 30, 2022 177.18 Mn
Jun 30, 2022 164.02 Mn
Mar 31, 2022 161.25 Mn
Dec 31, 2021 166.00 Mn
Sep 30, 2021 142.87 Mn
API Access

Arcus Biosciences Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=RCUS&period=max&api_key=YOUR_API_KEY